TQH3906 capsule

DRUG3 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

PsoriasisPsoriatic ArthritisSystemic Lupus Erythematosus

Phase 1

A Clinical Trial of TQH3906 Capsules in Healthy Volunteers

CompletedNCT06230588

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Psoriasis

Start: 2024-02-02End: 2025-04-27Updated: 2025-07-16

Phase 2

A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis

RecruitingNCT07406035

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Psoriatic Arthritis

Start: 2026-07-16End: 2027-11-01Target: 156Updated: 2026-09-02

A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

RecruitingNCT07509892

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Systemic Lupus Erythematosus

Start: 2026-06-22End: 2028-03-01Target: 198Updated: 2026-07-08